1. Please check and comment entries here.
Table of Contents

    Topic review

    Alveologenesis

    View times: 5
    Submitted by:

    Definition

    Alveologenesis is the final stage of lung maturation, when an alveolar region is divided into smaller units called alveoli via the process known as secondary septation. Each of the formed septa serves as a new gas exchange surface, and all together, they dramatically increase the respiratory surface area. Alveologenesis is divided into 2 phases: classical and continued. During the classical alveologenesis, the secondary septa are formed and the number of alveoli increases. During the continued alveologenesis, the maturation and thinning of the septa occur and the size of alveoli increases. The disruption of alveologenesis leads to the simplification of the alveoli, as seen in preterm infants diagnosed with bronchopulmonary dysplasia (BPD), a widespread pulmonary disease that is often connected with lifelong respiratory failure.

    1. Introduction

    The postnatal development of alveoli is the most important and less investigated phase of lung development. The pathology of alveolar formation is often detected during the occurrence of pulmonary diseases in adults and children. However, the mechanisms of alveologenesis remain mostly understudied.
    Alveologenesis is the final stage of lung maturation, when an alveolar region is divided into smaller units called alveoli via the process known as secondary septation. Each of the formed septa serves as a new gas exchange surface, and all together, they dramatically increase the respiratory surface area. The disruption of alveologenesis leads to the simplification of the alveoli, as seen in preterm infants diagnosed with bronchopulmonary dysplasia (BPD), a widespread pulmonary disease that is often connected with lifelong respiratory failure. There are approaches that can be used to study lung development, including alveologenesis. Among them is the cultivation of cells and lung slices in vitro. Pieretti et al. showed that P4 lungs inflated with agarose and grown for four days, embedded in a collagen matrix, appear to septate similarly to lungs that grow in vivo [1]. Live images of alveologenesis in precision-cut lung slices can reveal dynamic cell behavior [2]. Lung organoids and lung-on-a-chip techniques can also serve as models for the investigation of lung development, functions, and respiratory diseases [3][4]. Much information about signaling pathways has been obtained using mouse models with cell-specific gene ablations, some of which will be described here. In vivo models of alveoli regeneration such as lung regeneration after an injury caused by exposure to smoke or chemicals or the realveolarization after partial pneumonectomy (PNX) also play an important role in understanding pulmonary alveologenesis. The development of alveoli is regulated by a complex network of signaling pathways, which involve different pulmonary cell types. Lung mesenchyme cells, such as alveolar myofibroblasts [5], and also endothelial cells [6] are considered to be drivers of alveolar development. Epithelial–mesenchymal interactions are known to regulate lung morphogenesis, while the mesenchyme possesses induction activity [7][8] and consists of multiple cell subpopulations, which differ in spatial arrangement and functions. Among them are airway and vascular smooth muscle cells; pericytes; interstitial myo-, matrix-, and lipofibroblats; the recently revealed myofibrogenic progenitor cells, which preferentially generate abnormal myofibroblasts after injury; alveolar niche cells necessary for the maintenance of epithelial proliferation and differentiation [9]; and mesenchymal stem cells, the rare and poorly described population of progenitors with proliferative potential that are activated after injury and are able to differentiate in several mesenchymal cell types. Identifying origin distinctions of fibroblast-like cells is a very difficult task. The activation of ligands and receptors of the main pathways used for clone tracing in the mesenchyme strongly depends on context. Despite the availability of single-cell RNA sequencing (scRNAseq) data allowing for the identification of the profile of mesenchymal lung cell subpopulations, isolating these cells by their characteristic markers remains difficult, given that their functionality and heterogeneity changes during development. One single signaling pathway can be activated in multiple fibroblast subpopulations. Cells repeatedly activate the same signaling pathways during lung development and regeneration after injury; however, at the same time, they can function as rather distinct clones. Thus, the moment of activation of the lineage marker (signaling pathway molecules) plays an important role in progenitor identification and the determination of its lineage trajectory [10]. Cell subpopulations are rather thought to be transient states, common for this or that subtype of interstitial fibroblasts than definite cell types. In adults, pulmonary diseases such as chronic obstructive pulmonary disease (COPD) and lung fibrosis are connected with the impairment of alveolar regeneration. Despite the apparent variety of studies and literature on lung development, specifically postnatal development, and the use of modern techniques such as scRNAseq, the data on alveologenesis are rather scattered and do not provide a holistic idea of the complex of cellular, mechanical, and molecular interactions that ensure the formation and regeneration of alveoli.

    2. Briefly about Embryonic Lung Development

    Lung development in mice begins at around E9.5. It can be divided into the pseudoglandular (E10.5–E16.5), canalicular (E16.5–E17.5), saccular (E17.5–P5), and alveolar (P3–P30 (P39)) phases according to morphological features (Figure 1).
    Figure 1. Lung development. Development of the lung as a whole and its proximal parts is shown in blue. Development of the distal lung and alveologenesis is shown in purple. E, embryonic day; P, postnatal day. The timescale, shown in weeks, refers to the stages of human lung development.

    3. Elastogenesis and Collagens in Alveologenesis

    ECM plays an important role in lung development, normal functioning, and repair after injury. The main components of the matrix are elastin, fibronectin, collagens I, III, IV, VI, and XVII, laminins, proteoglycans, and glycoproteins. Many diseases that affect the structure and function of the lung are accompanied by the dysregulation of basement membrane components [11][12][13]. While it is well known that the overexpression of collagen fibers causes lung fibrosis, there is not much information on the role of collagens in alveologenesis. Loscertales and colleagues showed that collagen IV is essential in alveolar lung patterning and proposed a model in which collagen IV regulates epithelial and endothelial components important for alveologenesis, induces (in part through the PDGFRα pathway) interstitial αSMA myofibroblasts to proliferate and migrate to the tips of the septa during early septation, and later contributes to the extension and final maturation of secondary septa [14]. As Col4a1 mRNA is expressed in the interstitium and the tips of alveolar septa in a pattern similar to tropoelastin, the authors suggest that collagen IV regulates elastogenesis specifically in the αSMA+ cell population. Moreover, Col4a1 mutants have an increased number of cells with lipid content (AT2 and lipofibroblasts) and abnormal capillary formation. An interesting observation is that collagen VI promotes lung epithelial cell spreading and increases the rate of “wound healing” in response to a scratch injury via phosphoinositide 3-kinase (PI3k) and the cell division control 42 homolog (CDC42) downstream of the interaction with b1 integrins [15].
    Among the lung ECM components, collagen fibers (mainly type I and III), which are stiff and strong, provide structural integrity and strength to the lung and are the most important load-bearing element within the alveolar duct and wall, while elastic fibers provide tissue resilience [16]. Degradation of elastic fibers by elastases (e.g., smoking induces the secretion of elastases from inflammatory cells, and mice deficient in macrophage elastase were resistant to tobacco smoking that normally provokes emphysema in wild-type mice, which was shown by [17]) or aging give rise to emphysema. The formation of functional elastin fibers, which give elasticity to the alveoli, plays a crucial role in the process of alveologenesis. Tropoelastin, a soluble monomer of mature elastin, is a spring-like molecule that is extremely flexible and extensible [18]. In this manner, elastin itself possesses remarkable durability and thus the ability to undergo many stretch–recoil cycles while maintaining the structural and functional integrity of elastic tissues throughout life. Elastogenesis is a highly hierarchical multistep process [19]. Elastin and fibrillin-1 (FBN1) represent the building blocks of elastic fibers that compose the elastic fiber core and microfibrils, respectively [20]. The formation of elastic fibers requires several accessory proteins, including fibulin-4, fibulin-5, and the latent TGF-beta binding protein, LTBP-4, which shares structural homology with FBN1 [21][22].
    Elastin is expressed in the lung by several types of cells, including pleural mesothelial cells, airway and blood vessel smooth muscle cells, endothelial cells, and interstitial fibroblasts. Due to this, a system of elastic fibers is formed, which ensures an equal transfer of the applied force to all parts of the lung [23]. Numerous studies show that the formation of alveoli is closely related to the formation of elastin fibers in the respiratory region of the lung. During septation, the formation of elastin fibers reaches its peak. Three phases of tropoelastin expression have been observed in the developing lung, with each phase characterized by a distinct expression pattern [24]. In the first phase, on E15.5, the expression of tropoelastin mRNA was confined to mesenchymal cells lining the proximal tubules of the endoderm. During the second phase of expression, at the saccular stage on E18.5, almost all lung mesenchyme was tropoelastin-positive. It was also expressed in the developing vascular walls. In the third phase, on P7–P14, tropoelastin expression was limited to a population of mesenchymal cells located on the tips of the growing alveolar septa (and to developing cells of the vascular and bronchial walls). Mesenchymal tropoelastin-positive cells detected in the third phase of postnatal expression were specifically and completely absent in the lung of PDGF-A−/− mice, while tropoelastin expression in bronchial and blood vessel walls was unaffected. The impairment of postnatal alveologenesis in PDGF-A−/− mice was suggested to be due to a prenatal block in the distal distribution of PDGFRα+ cells [24]. In the absence of a PDGF-A signal, PDGFRα+ cells are unable to multiply and spread. Thus, the depletion of myofibroblasts in PDGF-A-null mice results in a lack of elastic fibers in the alveolar walls and incomplete alveolarization [25][24]. Similar effects were observed in Hoxa5−/− murine lung, in which the subset of the mesenchymal progenitors of alveolar αSMA+ myofibroblasts expressing Pdgfrα failed to spread into the distal fetal lung [26]. They were trapped in the parenchyma surrounding future alveoli, where they produced abnormal elastic fibers. Elastic fibers were disorganized and aberrantly distributed within the pulmonary tissue on P0 and P5, and alveologenesis was impaired. From P15 onwards, the fibers appeared more abundant, disorganized, and fragmented. Northern blot analyses of tropoelastin expression failed to reveal differences in tropoelastin transcript levels between wild-type and Hoxa5−/− lungs. Later, it was shown that Hox5 genes are required in elastin network formation by regulating the adherence of the alveolar fibroblasts to fibronectin, which is disrupted because of the loss of the integrin heterodimer Itga5b1 in mutant fibroblasts [27]. In Hoxa5 mutants, the activated macrophages were abundantly found in the lung as early as birth, and most of them expressed matrix metalloproteinase 12 (MMP12). This recruitment coincided with the abnormal elastin deposition by the mispositioned alveolar myofibroblasts, supporting the notion that elastin fragments are chemotactic for monocytes [28]. Furthermore, recent studies showed that the absence of Pdgfra in Gli1+ SCMFs disrupted the expression of elastogenic genes, including members of the LOX, fibronectin, and fibulin families, while the expression of the EGF family members was increased, and Tgfb1 was suppressed in the lung fibroblasts of the studied mice. Similar results were found in lung samples from a person with BPD. Blocking PDGF-A signaling in vitro had the same effect. In addition, the effect was reversible by inhibiting EGF or activating TGF-beta signaling. These data demonstrate the role of PDGFA/PDGFRα in the control of elastogenic gene expression through the secondary level of signaling networks consisting of EGF and TGF-beta [29]. Finally, the growth factor FGF-18 was also shown to affect myofibroblast differentiation by stimulating the expression of tropoelastin, LOX, and fibulins 1 and 5 during secondary septation [30].
    Some methods that suppress alveolarization, such as prolonged hyperoxia (BPD modeling), also suppress septation and elastin expression in the alveolar wall [31][32][33][34]. Elastin fiber assembly impairment in newborn rats due to copper deficiency [35] or the administration of beta-Aminopropionitrile (beta APN) [36], which interferes with the synthesis of elastin and collagen by inhibiting LOX, results in the impairment of alveolar septa formation and the simplification of the alveoli by the type of emphysema. In contrast to PDGF-A−/− mice, in which the absence of alveolar elastin synthesis and the abnormal structure of the alveoli are detected after P4, the inactivation of the elastin gene in Eln−/− mice leads to a delay in the perinatal development of the terminal airway branches. At birth, these mice have enlarged cavities in the lung that resemble emphysema [37]. These differences indicate that, in addition to its role in the formation of the structure of alveoli, elastin is important for the terminal branching of the airways in lung development. This also supports the idea that elastin is expressed by airway smooth muscle cells, which enwrap the branching tips and the stalk of the primordial airways and physically support branching morphogenesis [38][39].
    In the developing fetal lung, the interplay between the epithelium and the mesenchyme surrounding it is a driving force that guides the formation of the proximal–distal pattern. Respiratory mesoderm originates from the cardio-pulmonary precursors expressing Wnt2, Gli1, and Isl1 and generates vascular and airway smooth muscle cells, proximal vascular endothelium, and pericyte-like cells [40]. Tbx4 is expressed in the population of the mesenchymal cells that give rise to the entire stroma of the postnatal lung. TBX4-positive mesenchymal precursor cells proliferate and differentiate into different cell types, simultaneously cooperating with the developing lung epithelium [41][42]. In the regions adjacent to the endoderm of the distal tip, mesodermal cells express FGF10, which stimulates branching morphogenesis [43][44][45][46]. In the fetal and postnatal lung, FGF10+ cells represent the pool of mesenchymal progenitor cells [47]. The endoderm of the distal tip expresses SOX9 and ID2. Endodermal cells respond to WNT and the chemoattracting and morphogenic action of mesodermal FGF10 (for the review, see [48]). The Shh and Ptch1 expression patterns are the reverse of the expression patterns of Fgf10 and Fgfr2b in that the Shh ligand is expressed in the epithelium, which is of endodermal origin, while the Ptch1 receptor is expressed in the mesenchyme [49]. The formation of a vast branching network of airways is partly explained by a signaling mechanism based on a ligand–receptor interplay between Fgf10 and Shh, which directs the outgrowth of the lung bud via a ligand–receptor-based Turing mechanism, and is additionally determined by a geometry effect of the lung [50]. The lung mesenchyme possesses positional information and anatomical specificity: proximal and distal mesenchyme can induce the corresponding proximal and distal differentiation of the lung epithelium [7][8]. In 1994, Shannon was already able to show the induction of alveolar type II cell differentiation in fetal tracheal epithelium by the transplanted distal lung mesenchyme [7].
    During the pseudoglandular stage, the recurrent processes of outgrowth and branching of the lung endoderm (branching morphogenesis) are initialized, by which all the future respiratory airways (bronchi and bronchioli) are formed (Figure 1). It is interesting to note that the specification of alveolocyte clones occurs earlier than it was supposed before; more specifically, it runs in parallel to the processes of tissue patterning, including the formation of the axial endoderm pattern and branching morphogenesis [51]. At the end of branching morphogenesis on E15.5, precursors of the alveolar type 1 and 2 cells (AT1 and AT2) are detected in the bud tips [5]. During the canalicular phase, the differentiation of the epithelium can be detected (via alveolocyte marker staining), and the junctions of bronchiolar ducts, which are the extensions of the conducting airways, are formed. Further in development, the enlargements (saccules) are formed along the branching tree, thus marking the saccular phase (Figure 1). Separations between initial alveolar sacs are known as primary septa. Several authors also designate this phase as initial alveologenesis. Primary septa are not effective in the formation of the air–blood barrier and full breathing. Thus, the survival of an individual depends on the timely and accurate formation of the secondary septa. Mice are born in the saccular phase of lung development. The formation of their secondary septa and alveoli occurs after birth. In humans, alveologenesis begins in utero on the 36th week of gestation (Figure 1), and classical alveologenesis continues for 2–3 years after birth, when the number of alveoli increases. Afterwards, from 3 until 21 years, the size of alveoli increases [52].

    4. Postnatal Alveologenesis

    The formation of the alveoli (alveologenesis) is the final stage of lung development and is subdivided into two phases (Figure 1). The first phase begins on the 3rd–4th day of postnatal development (P3–P4), and is characterized by the formation of the secondary septa, which represent the invaginations of the saccular walls rich in ECM and separate and expand the alveolar surface area [53]. Around P3, as the breathing mode is established, a subpopulation of the secondary crest myofibroblasts (SCMFs, also known as alveolar myofibroblasts) with increased traction force appears in the lung mesenchyme [5]. SCMFs participate in secondary septa formation and actively accept different signals from AT1 cells. Contractile activity of myofibroblasts is supposed to physically form alveoli [54]. SCMF precursors are the subpopulation of platelet-derived growth factor receptor α (PDGFRα) positive cells that later in embryonic development become α-smooth muscle actin (αSMA) positive and are found on the tips of the alveolar septa in close proximity to deposits of elastin (Figure 2A).
    Figure 2. Alveolar secondary septa. Classical alveologenesis. Immature, thick secondary septa. Double capillary network (A). Continued alveologenesis. Mature, thin secondary septa. Single capillary network (B). Redrawn from [52][55].
    PDGF-A and its sole receptor PDGFRα constitute an axis of cross-communication between pulmonary endodermal and mesodermal cells [25]. Endodermal cells express the ligand [25], and PDGFRα is ubiquitously expressed throughout the lung mesoderm [56][57]. Earlier, PDGF-A signaling over PDGFRα was shown to be necessary for lung growth and alveoli formation, but not for branching morphogenesis [58]. According to a widespread model of septa formation, PDGF-A secreted by the epithelium is extruded into the lumen of alveoli by the exerting force of myofibroblasts and developing capillary. Then, the septa are thinned through the processes of apoptosis and capillary maturation [59][60]. Impaired Notch signaling in mice, especially Notch2, results in the abnormal enlargement of the alveoli. During neonatal life, Notch2 is activated in AT2 cells to induce PDGF-A expression, triggering the paracrine activation of PDGFRα signaling in the SCMF precursors required for alveologenesis [61]. The first phase of alveologenesis, from around P5 to P14, when SCMFs are present, is called classical alveologenesis (Figure 2A). During the second phase of alveologenesis (continued alveologenesis), from around P14 to P36, formed immature septa start thinning, the double capillary septal network is modified to a single one, thus forming mature, thin septa in an adult lung (Figure 2B) [60]. After the active phase of alveologenesis is completed, more than 20% of interstitial fibroblasts are subjected to apoptosis, a process that is crucial for the normal development of the lung [62][63]. Nevertheless, taking into account the cell heterogeneity of the mesenchymal compartment, the question of which subpopulation of fibroblasts is eliminated thus becomes controversial [62][63][64]. There is an opinion that the thinning of the alveolar walls during the second phase of alveologenesis is caused by the depletion of lung myofibroblasts after around P15 through apoptosis and phagocytosis [65]. The flow cytometry evaluation of lipid-filled interstitial fibroblasts stained with a lipophilic marker showed that this exact subpopulation is eliminated via apoptosis after alveolarization [66]. Results of several studies have suggested the temporal expression of αSMA by some subpopulations of alveolar mesenchymal cells that play the role of SCMFs and are not eliminated afterwards [67][68]. Multiple data have demonstrated that myofibroblasts are crucial for secondary septa formation, but the mechanisms of αSMA+ SCMFs depletion after the first phase, and the question of which cells and mechanisms participate in the second phase of alveologenesis after the elimination of αSMA+ SCMFs by P15, are the subject of future investigations.
    Alveolar density reaches its peak on P39 and stays unchanged after 9 months. The generation of alveoli is fast between P5 and P14, but slows down afterwards [69]. As mentioned before, immature secondary septa have a double capillary network and are quite ineffective in the required gas exchange (Figure 2A). During the maturation of the blood microvessels, the septa start thinning and two capillary layers merge and thus form a more effective single capillary network (Figure 2B) (for the review, see [52]). The single capillary network exchanges oxygen and carbon dioxide with two adjacent alveoli, which adds to the efficacy of the gas exchange. On P4–P21, new secondary septa are formed from immature secondary septa emerging at first from the walls of saccules, and further in development from the walls of immature secondary septa with the double capillary network. On days P14–P36, new septa are lifted off mature septa containing single capillary networks (Figure 2). At the same time, the local duplication of the capillary network due to angiogenesis is found at the base of the newly formed septa in the second phase of alveologenesis. The alveolarization and maturation of microvessels are the processes that run in parallel [70]. Lung development continues into young adulthood: for mice, data are known up to P39 [69], for rats, up to P60 [71]. Alveoli are, in fact, able to form at any time and anywhere inside the lung parenchyma [52]. Thus, in the alveolar septum, the air–blood barrier has thick parts that contain the nuclei of AT1 cells and fibroblasts and the fiber network of ECM, which provides the regenerative capacity and mechanical stability of the septum; it also has thin parts where the alveolar epithelium and the capillary endothelium share one common basal lamina that minimize the thickness of the diffusion barrier. In the human lung, about half of the entire air–blood barrier is thin [72][73].

    This entry is adapted from 10.3390/ijms222212107

    References

    1. Pieretti, A.C.; Ahmed, A.M.; Roberts, J.D., Jr.; Kelleher, C.M. A Novel in vitro Model to Study Alveologenesis. Am. J. Respir. Cell Mol. Biol. 2013, 50, 459–469.
    2. Akram, K.M.; Yates, L.L.; Mongey, R.; Rothery, S.; Gaboriau, D.C.A.; Sanderson, J.; Hind, M.; Griffiths, M.; Dean, C.H. Live Imaging of Alveologenesis in Precision-Cut Lung Slices Reveals Dynamic Epithelial Cell Behaviour. Nat. Commun. 2019, 10, 1178.
    3. Gkatzis, K.; Taghizadeh, S.; Huh, D.; Stainier, D.Y.R.; Bellusci, S. Use of three-dimensional organoids and lung-on-a-chip methods to study lung development, regeneration and disease. Eur. Respir. J. 2018, 52, 1800876.
    4. Li, Y.; Wu, Q.; Sun, X.; Shen, J.; Chen, H. Organoids as a Powerful Model for Respiratory Diseases. Stem Cells Int. 2020, 2020, 5847876.
    5. Zepp, J.A.; Morley, M.P.; Loebel, C.; Kremp, M.M.; Chaudhry, F.N.; Basil, M.C.; Leach, J.P.; Liberti, D.C.; Niethamer, T.K.; Ying, Y.; et al. Genomic, epigenomic, and biophysical cues controlling the emergence of the lung alveolus. Science 2021, 371, eabc3172.
    6. Vila Ellis, L.; Cain, M.P.; Hutchison, V.; Flodby, P.; Crandall, E.D.; Borok, Z.; Zhou, B.; Ostrin, E.J.; Wythe, J.D.; Chen, J. Epithelial Vegfa Specifies a Distinct Endothelial Population in the Mouse Lung. Dev. Cell 2020, 52, 617–630.e6.
    7. Shannon, J.M. Induction of Alveolar Type II Cell Differentiation in Fetal Tracheal Epithelium by Grafted Distal Lung Mesenchyme. Dev. Biol. 1994, 166, 600–614.
    8. Shannon, J.M.; Nielsen, L.D.; Gebb, S.A.; Randell, S.H. Mesenchyme specifies epithelial differentiation in reciprocal recombinants of embryonic lung and trachea. Dev. Dyn. 1998, 212, 482–494.
    9. Zepp, J.A.; Zacharias, W.J.; Frank, D.B.; Cavanaugh, C.A.; Zhou, S.; Morley, M.P.; Morrisey, E.E. Distinct Mesenchymal Lineages and Niches Promote Epithelial Self-Renewal and Myofibrogenesis in the Lung. Cell 2017, 170, 1134–1148.e10.
    10. Riccetti, M.; Gokey, J.J.; Aronow, B.; Perl, A.-K.T. The elephant in the lung: Integrating lineage-tracing, molecular markers, and single cell sequencing data to identify distinct fibroblast populations during lung development and regeneration. Matrix Biol. 2020, 91–92, 51–74.
    11. Burgstaller, G.; Oehrle, B.; Gerckens, M.; White, E.S.; Schiller, H.B.; Eickelberg, O. The instructive extracellular matrix of the lung: Basic composition and alterations in chronic lung disease. Eur. Respir. J. 2017, 50, 1601805.
    12. Zhou, Y.; Horowitz, J.C.; Naba, A.; Ambalavanan, N.; Atabai, K.; Balestrini, J.; Bitterman, P.B.; Corley, R.A.; Ding, B.-S.; Engler, A.J.; et al. Extracellular matrix in lung development, homeostasis and disease. Matrix Biol. 2018, 73, 77–104.
    13. Mereness, J.A.; Mariani, T.J. The critical role of collagen VI in lung development and chronic lung disease. Matrix Biol. Plus 2021, 10, 100058.
    14. Loscertales, M.; Nicolaou, F.; Jeanne, M.; Longoni, M.; Gould, D.B.; Sun, Y.; Maalouf, F.I.; Nagy, N.; Donahoe, P.K. Type IV collagen drives alveolar epithelial-endothelial association and the morphogenetic movements of septation. BMC Biol. 2016, 14, 59.
    15. Mereness, J.A.; Bhattacharya, S.; Wang, Q.; Ren, Y.; Pryhuber, G.S.; Mariani, T.J. Type VI collagen promotes lung epithelial cell spreading and wound-closure. PLoS ONE 2018, 13, e0209095.
    16. Suki, B.; Ito, S.; Stamenovic, D.; Lutchen, K.R.; Ingenito, E.P. Biomechanics of the lung parenchyma: Critical roles of collagen and mechanical forces. J. Appl. Physiol. 2005, 98, 1892–1899.
    17. Hautamaki, R.D.; Kobayashi, D.K.; Senior, R.M.; Shapiro, S.D. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997, 277, 2002–2004.
    18. Ozsvar, J.; Yang, C.; Cain, S.A.; Baldock, C.; Tarakanova, A.; Weiss, A.S. Tropoelastin and Elastin Assembly. Front. Bioeng. Biotechnol. 2021, 9, 643110.
    19. Papke, C.L.; Yanagisawa, H. Fibulin-4 and fibulin-5 in elastogenesis and beyond: Insights from mouse and human studies. Matrix Biol. 2014, 37, 142–149.
    20. Shin, S.J.; Yanagisawa, H. Recent updates on the molecular network of elastic fiber formation. Essays Biochem. 2019, 63, 365–376.
    21. Yamauchi, Y.; Tsuruga, E.; Nakashima, K.; Sawa, Y.; Ishikawa, H. Fibulin-4 and -5, but not Fibulin-2, are Associated with Tropoelastin Deposition in Elastin-Producing Cell Culture. ACTA Histochem. Cytochem. 2010, 43, 131–138.
    22. Noda, K.; Dabovic, B.; Takagi, K.; Inoue, T.; Horiguchi, M.; Hirai, M.; Fujikawa, Y.; Akama, T.O.; Kusumoto, K.; Zilberberg, L.; et al. Latent TGF-β binding protein 4 promotes elastic fiber assembly by interacting with fibulin-5. Proc. Natl. Acad. Sci. USA 2013, 110, 2852–2857.
    23. Mecham, R.P. Elastin in lung development and disease pathogenesis. Matrix Biol. 2018, 73, 6–20.
    24. Lindahl, P.; Karlsson, L.; Hellström, M.; Gebre-Medhin, S.; Willetts, K.; Heath, J.K.; Betsholtz, C. Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. Dev. Camb. Engl. 1997, 124, 3943–3953.
    25. Boström, H.; Willetts, K.; Pekny, M.; Levéen, P.; Lindahl, P.; Hedstrand, H.; Pekna, M.; Hellström, M.; Gebre-Medhin, S.; Schalling, M.; et al. PDGF-A Signaling Is a Critical Event in Lung Alveolar Myofibroblast Development and Alveogenesis. Cell 1996, 85, 863–873.
    26. Mandeville, I.; Aubin, J.; LeBlanc, M.; Lalancette-Hébert, M.; Janelle, M.-F.; Tremblay, G.M.; Jeannotte, L. Impact of the Loss of Hoxa5 Function on Lung Alveogenesis. Am. J. Pathol. 2006, 169, 1312–1327.
    27. Hrycaj, S.M.; Marty-Santos, L.; Cebrian, C.; Rasky, A.J.; Ptaschinski, C.; Lukacs, N.W.; Wellik, D.M. Hox5 genes direct elastin network formation during alveologenesis by regulating myofibroblast adhesion. Proc. Natl. Acad. Sci. USA 2018, 115, E10605–E10614.
    28. Parks, W.C.; Shapiro, S.D. Matrix metalloproteinases in lung biology. Respir. Res. 2001, 2, 10–19.
    29. Li, C.; Lee, M.K.; Gao, F.; Webster, S.; Di, H.; Duan, J.; Yang, C.-Y.; Bhopal, N.; Peinado, N.; Pryhubar, G.; et al. The secondary crest myofibroblast PDGFRα controls elastogenesis pathway via a secondary tier of signaling networks during alveologenesis. Development 2019, 146, dev.176354.
    30. Chailley-Heu, B.; Boucherat, O.; Barlier-Mur, A.-M.; Bourbon, J.R. FGF-18 is upregulated in the postnatal rat lung and enhances elastogenesis in myofibroblasts. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2005, 288, L43–L51.
    31. Bruce, M.C.; Pawlowski, R.; Tomashefski, J.F. Changes in Lung Elastic Fiber Structure and Concentration Associated with Hyperoxic Exposure in the Developing Rat Lung. Am. Rev. Respir. Dis. 1989, 140, 1067–1074.
    32. Bruce, M.C.; Bruce, E.N.; Janiga, K.; Chetty, A. Hyperoxic exposure of developing rat lung decreases tropoelastin mRNA levels that rebound postexposure. Am. J. Physiol.-Lung Cell. Mol. Physiol. 1993, 265, L293–L300.
    33. Blanco, L.N.; Frank, L. The Formation of Alveoli in Rat Lung during the Third and Fourth Postnatal Weeks: Effect of Hyperoxia, Dexamethasone, and Deferoxamine. Pediatr. Res. 1993, 34, 334–340.
    34. Dylag, A.M.; Haak, J.; Yee, M.; O’Reilly, M.A. Pulmonary mechanics and structural lung development after neonatal hyperoxia in mice. Pediatr. Res. 2020, 87, 1201–1210.
    35. O’Dell, B.L.; Kilburn, K.H.; McKenzie, W.N.; Thurston, R.J. The lung of the copper-deficient rat. A model for developmental pulmonary emphysema. Am. J. Pathol. 1978, 91, 413–432.
    36. Kida, K.; Thurlbeck, W.M. The effects of beta-aminopropionitrile on the growing rat lung. Am. J. Pathol. 1980, 101, 693–710.
    37. Wendel, D.P.; Taylor, D.G.; Albertine, K.H.; Keating, M.T.; Li, D.Y. Impaired Distal Airway Development in Mice Lacking Elastin. Am. J. Respir. Cell Mol. Biol. 2000, 23, 320–326.
    38. Kim, H.Y.; Pang, M.-F.; Varner, V.D.; Kojima, L.; Miller, E.; Radisky, D.C.; Nelson, C.M. Localized Smooth Muscle Differentiation Is Essential for Epithelial Bifurcation during Branching Morphogenesis of the Mammalian Lung. Dev. Cell 2015, 34, 719–726.
    39. Goodwin, K.; Mao, S.; Guyomar, T.; Miller, E.; Radisky, D.C.; Košmrlj, A.; Nelson, C.M. Smooth muscle differentiation shapes domain branches during mouse lung development. Development 2019, 146, dev.181172.
    40. Peng, T.; Tian, Y.; Boogerd, C.J.; Lu, M.M.; Kadzik, R.S.; Stewart, K.M.; Evans, S.M.; Morrisey, E.E. Coordination of heart and lung co-development by a multipotent cardiopulmonary progenitor. Nature 2013, 500, 589–592.
    41. Zhang, W.; Menke, D.B.; Jiang, M.; Chen, H.; Warburton, D.; Turcatel, G.; Lu, C.-H.; Xu, W.; Luo, Y.; Shi, W. Spatial-temporal targeting of lung-specific mesenchyme by a Tbx4 enhancer. BMC Biol. 2013, 11, 111.
    42. Kumar, M.E.; Bogard, P.E.; Espinoza, F.H.; Menke, D.B.; Kingsley, D.M.; Krasnow, M.A. Defining a mesenchymal progenitor niche at single-cell resolution. Science 2014, 346, 1258810.
    43. Bellusci, S.; Grindley, J.; Emoto, H.; Itoh, N.; Hogan, B.L. Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung. Development 1997, 124, 4867–4878.
    44. Weaver, M.; Dunn, N.R.; Hogan, B.L. Bmp4 and Fgf10 play opposing roles during lung bud morphogenesis. Development 2000, 127, 2695–2704.
    45. Abler, L.L.; Mansour, S.L.; Sun, X. Conditional gene inactivation reveals roles for Fgf10 and Fgfr2 in establishing a normal pattern of epithelial branching in the mouse lung. Dev. Dyn. 2009, 238, 1999–2013.
    46. Clément, R.; Blanc, P.; Mauroy, B.; Sapin, V.; Douady, S. Shape Self-Regulation in Early Lung Morphogenesis. PLoS ONE 2012, 7, e36925.
    47. El Agha, E.; Herold, S.; Alam, D.A.; Quantius, J.; MacKenzie, B.; Carraro, G.; Moiseenko, A.; Chao, C.-M.; Minoo, P.; Seeger, W.; et al. Fgf10 -positive cells represent a progenitor cell population during lung development and postnatally. Development 2014, 141, 296–306.
    48. Zepp, J.A.; Morrisey, E.E. Cellular crosstalk in the development and regeneration of the respiratory system. Nat. Rev. Mol. Cell Biol. 2019, 20, 551–566.
    49. Bellusci, S.; Furuta, Y.; Rush, M.G.; Henderson, R.; Winnier, G.; Hogan, B.L. Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis. Development 1997, 124, 53–63.
    50. Menshykau, D.; Blanc, P.; Unal, E.; Sapin, V.; Iber, D. An interplay of geometry and signaling enables robust lung branching morphogenesis. Development 2014, 141, 4526–4536.
    51. Frank, D.B.; Penkala, I.J.; Zepp, J.A.; Sivakumar, A.; Linares-Saldana, R.; Zacharias, W.J.; Stolz, K.G.; Pankin, J.; Lu, M.; Wang, Q.; et al. Early lineage specification defines alveolar epithelial ontogeny in the murine lung. Proc. Natl. Acad. Sci. USA 2019, 116, 4362–4371.
    52. Schittny, J.C. Development of the lung. Cell Tissue Res. 2017, 367, 427–444.
    53. Mund, S.I.; Stampanoni, M.; Schittny, J.C. Developmental alveolarization of the mouse lung. Dev. Dyn. 2008, 237, 2108–2116.
    54. Li, R.; Li, X.; Hagood, J.; Zhu, M.-S.; Sun, X. Myofibroblast contraction is essential for generating and regenerating the gas-exchange surface. J. Clin. Investig. 2020, 130, 2859–2871.
    55. Ushakumary, M.G.; Riccetti, M.; Perl, A.T. Resident interstitial lung fibroblasts and their role in alveolar stem cell niche development, homeostasis, injury, and regeneration. Stem Cells Transl. Med. 2021, 10, 1021–1032.
    56. Orr-Urtreger, A.; Lonai, P. Platelet-derived growth factor-A and its receptor are expressed in separate, but adjacent cell layers of the mouse embryo. Development 1992, 115, 1045–1058.
    57. Gouveia, L.; Betsholtz, C.; Andrae, J. Expression analysis of platelet-derived growth factor receptor alpha and its ligands in the developing mouse lung. Physiol. Rep. 2017, 5, e13092.
    58. Boström, H.; Gritli-Linde, A.; Betsholtz, C. PDGF-a/PDGF alpha-receptor signaling is required for lung growth and the formation of alveoli but not for early lung branching morphogenesis: Lung Development in PDGF Receptor Alpha-Deficient Mice. Dev. Dyn. 2002, 223, 155–162.
    59. Prodhan, P.; Kinane, T.B. Developmental paradigms in terminal lung development. BioEssays 2002, 24, 1052–1059.
    60. Burri, P.H. Structural Aspects of Postnatal Lung Development–Alveolar Formation and Growth. Neonatology 2006, 89, 313–322.
    61. Tsao, P.-N.; Matsuoka, C.; Wei, S.-C.; Sato, A.; Sato, S.; Hasegawa, K.; Chen, H.; Ling, T.-Y.; Mori, M.; Cardoso, W.V.; et al. Epithelial Notch signaling regulates lung alveolar morphogenesis and airway epithelial integrity. Proc. Natl. Acad. Sci. USA 2016, 113, 8242–8247.
    62. Schittny, J.C.; Djonov, V.; Fine, A.; Burri, P.H. Programmed Cell Death Contributes to Postnatal Lung Development. Am. J. Respir. Cell Mol. Biol. 1998, 18, 786–793.
    63. Bruce, M.C.; Honaker, C.E.; Cross, R.J. Lung Fibroblasts Undergo Apoptosis Following Alveolarization. Am. J. Respir. Cell Mol. Biol. 1999, 20, 228–236.
    64. McGowan, S.E.; McCoy, D.M. Fibroblasts Expressing PDGF-Receptor-Alpha Diminish During Alveolar Septal Thinning in Mice. Pediatr. Res. 2011, 70, 44–49.
    65. Hagan, A.S.; Zhang, B.; Ornitz, D.M. Identification of an FGF18-expressing alveolar myofibroblast that is developmentally cleared during alveologenesis. Development 2020, 147, dev.181032.
    66. Srinivasan, S.; Strange, J.; Awonusonu, F.; Bruce, M.C. Insulin-like growth factor I receptor is downregulated after alveolarization in an apoptotic fibroblast subset. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2002, 282, L457–L467.
    67. Branchfield, K.; Li, R.; Lungova, V.; Verheyden, J.M.; McCulley, D.; Sun, X. A three-dimensional study of alveologenesis in mouse lung. Dev. Biol. 2016, 409, 429–441.
    68. Kugler, M.C.; Loomis, C.A.; Zhao, Z.; Cushman, J.C.; Liu, L.; Munger, J.S. Sonic Hedgehog Signaling Regulates Myofibroblast Function during Alveolar Septum Formation in Murine Postnatal Lung. Am. J. Respir. Cell Mol. Biol. 2017, 57, 280–293.
    69. Pozarska, A.; Rodríguez-Castillo, J.A.; Surate Solaligue, D.E.; Ntokou, A.; Rath, P.; Mižíková, I.; Madurga, A.; Mayer, K.; Vadász, I.; Herold, S.; et al. Stereological monitoring of mouse lung alveolarization from the early postnatal period to adulthood. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2017, 312, L882–L895.
    70. Schittny, J.C.; Mund, S.I.; Stampanoni, M. Evidence and structural mechanism for late lung alveolarization. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294, L246–L254.
    71. Tschanz, S.A.; Salm, L.A.; Roth-Kleiner, M.; Barré, S.F.; Burri, P.H.; Schittny, J.C. Rat lungs show a biphasic formation of new alveoli during postnatal development. J. Appl. Physiol. (1985) 2014, 117, 89–95.
    72. Weibel, E.R. Morphological basis of alveolar-capillary gas exchange. Physiol. Rev. 1973, 53, 419–495.
    73. Knudsen, L.; Ochs, M. The micromechanics of lung alveoli: Structure and function of surfactant and tissue components. Histochem. Cell Biol. 2018, 150, 661–676.
    More